US Earnings Financial Results SEC Filings — July 30, 2026

30-07-2026

Southern Power Company filed its quarterly report (10-Q) for the period ended June 30, 2026. The filing includes financial statements and management's discussion and analysis. No specific financial results are provided in the extracted content.

• · The filing is for the quarterly period ended June 30, 2026.
• · Southern Power Company is a wholly-owned subsidiary of The Southern Company.
• · Southern Power Company has 1,000 shares of common stock outstanding as of June 30, 2026.

30-07-2026

CRH reported net income of $1,511M for Q2 2026, up 13.4% from $1,332M in Q2 2025, and $1,331M for H1 2026, up 7.9% from $1,234M in H1 2025. Total revenues rose 5.6% to $10,777M in Q2 and 7.0% to $18,147M in H1. However, comprehensive income attributable to CRH fell 17.8% in Q2 to $1,463M and 36.8% in H1 to $1,191M, driven by a large currency translation loss of $102M in H1 versus a gain of $749M a year ago. Operating cash flow declined 28.7% to $513M in H1, while the company generated $1,676M in divestiture proceeds.

• · Americas Building Solutions revenue declined 1.9% in Q2 and 1.5% in H1, driven by a 5.8% drop in Outdoor Living Solutions to $1,551M in Q2 and a 4.9% drop to $2,748M in H1.
• · Operating cash flow fell 28.7% to $513M in H1 2026, primarily due to a $1,824M increase in accounts receivable (vs. $1,397M in H1 2025).
• · Cash and cash equivalents decreased 26.1% from $4,096M at Dec 31, 2025 to $3,025M at June 30, 2026.
• · The company generated $1,676M in proceeds from divestitures in H1 2026, compared to just $37M in H1 2025, and spent $1,110M on acquisitions (vs. $648M).
• · Long-term debt was reduced by 6.5% to $15,410M from $16,478M at year-end 2025.
• · Share repurchases totaled $607M in H1 2026, down from $644M in H1 2025; dividends paid increased to $521M from $500M.

30-07-2026

Aerkomm Inc. reported a net income of $4.79M for Q1 2026, a significant turnaround from a net loss of $3.68M in Q1 2025, driven primarily by a non-cash gain on remeasurement of retained investment upon deconsolidation of $8.33M. However, operating expenses remained high at $2.88M, and the company continues to report a stockholders' deficit of $2.03M, though improved from $7.35M at year-end 2025. Cash increased to $171,742 from $55,285, but the company remains heavily reliant on debt and related-party payables.

• · Total assets increased to $86.18M from $69.97M, driven largely by a $19.4M increase in long-term investment.
• · Total liabilities rose to $88.21M from $77.32M, with other payable - related parties surging 784% to $11.51M.
• · The company reported a gain on remeasurement of retained investment upon deconsolidation of $8.33M, which was the primary driver of net income.
• · Operating cash flow turned positive at $196,315 compared to a use of $590,312 in the prior year period.
• · Inventories remained nearly flat at $968,754 vs $969,039.
• · Prepayment for land remains a significant asset at $40.33M, slightly down from $40.42M.
• · The company has a working capital deficit of $83.35M (current liabilities of $88.02M exceed current assets of $4.66M).
• · No revenue was reported for either period; the company is still in a pre-revenue stage.

30-07-2026

Pilgrim's Pride Corporation reported a sharp decline in profitability for the second quarter and first half of fiscal 2026. Net income attributable to the company plunged 96% to $13.4M in Q2 2026 from $355.5M a year earlier, while net sales slipped 2.8% to $4.63B. The dramatic drop in earnings was driven by a 52.5% decline in gross profit to $339.8M and a 33% surge in SG&A expenses to $265.1M, partially offset by lower income tax expense.

• · Restructuring activities expense increased to $8.7M in Q2 2026 from $3.5M in Q2 2025.
• · Interest expense rose to $49.9M in Q2 2026 from $42.5M in Q2 2025.
• · Foreign currency transaction gains of $1.3M in Q2 2026 vs. losses of $4.9M in Q2 2025.
• · Total assets decreased to $10.03B as of June 28, 2026 from $10.34B as of December 28, 2025.
• · Total liabilities decreased to $6.27B from $6.65B over the same period.
• · Accumulated other comprehensive loss widened to $103.2M from $47.0M.
• · The company had no assets held for sale as of June 28, 2026, compared to $11.1M as of December 28, 2025.
• · Restricted cash and cash equivalents of $9.5M appeared on the balance sheet as of June 28, 2026, vs. zero at year-end 2025.

30-07-2026

Meta Platforms reported Q2 2026 revenue of $60.8B, up 28% YoY, and net income of $15.8B, down 14% YoY. For the first half of 2026, revenue rose 30% to $117.1B while net income increased 22% to $42.6B. However, operating income declined 8% in Q2 to $18.8B, and the company's cash and cash equivalents fell sharply from $35.9B at year-end 2025 to $15.5B, driven by heavy capital spending of $49.1B in H1 2026.

• · Total costs and expenses rose 55% YoY in Q2 2026 to $42.0B, driven by a 67% increase in R&D to $21.7B and a 111% increase in G&A to $5.6B.
• · Interest and other income (expense), net swung from a gain of $93M in Q2 2025 to a loss of $19M in Q2 2026.
• · The company issued $24.9B in long-term debt during H1 2026, contributing to a 42% increase in long-term debt to $83.7B.
• · No share repurchases occurred in H1 2026, compared to $22.9B in H1 2025.
• · Dividends declared were $0.525 per share in Q2 2026 ($1.05 per share in H1 2026), totaling $1.4B in Q2 and $2.8B in H1.
• · Property and equipment, net increased 28% from $176.4B at year-end 2025 to $225.7B.
• · Goodwill decreased 4.6% from $24.5B to $23.4B.
• · Accounts receivable increased 10% from $19.8B to $21.8B.
• · Accumulated other comprehensive income (loss) shifted from a gain of $271M to a loss of $603M.
• · The effective tax rate was 15.5% in Q2 2026 (provision of $2.9B on $18.8B pre-tax income) versus 10.7% in Q2 2025.

30-07-2026

Canadian Pacific Kansas City Ltd (CPKC) reported Q2 2026 total revenues of C$4,164M, up 12.6% YoY from C$3,699M, driven by freight revenue growth of 12.6% to C$4,088M. However, net income attributable to controlling shareholders declined 17.0% YoY to C$1,024M (from C$1,234M) due to the absence of a prior-year C$333M gain on sale of an equity investment and higher operating expenses. For the six-month period, revenues rose 4.9% to C$7,865M, while net income fell 12.8% to C$1,870M.

• · Coal freight revenue declined 18.4% YoY in Q2 2026 to C$209M (from C$256M).
• · Forest products freight revenue was nearly flat at C$198M in Q2 2026 vs C$195M in Q2 2025.
• · Energy, chemicals and plastics freight revenue grew 9.1% YoY to C$777M in Q2 2026.
• · Automotive freight revenue grew 22.1% YoY to C$403M in Q2 2026.
• · Intermodal freight revenue grew 10.8% YoY to C$758M in Q2 2026.
• · Grain freight revenue grew 24.5% YoY to C$925M in Q2 2026.
• · Total operating expenses increased 14.3% YoY to C$2,692M in Q2 2026.
• · Fuel expense increased 52.6% YoY to C$618M in Q2 2026.
• · Net debt (long-term debt including current portion minus cash) increased to C$24,781M as of June 30, 2026 from C$23,004M as of December 31, 2025.
• · Share repurchases totaled C$1,283M in Q2 2026, compared to C$1,393M in Q2 2025.
• · Dividends declared per share increased 17.5% YoY to C$0.268 in Q2 2026.

30-07-2026

Insperity, Inc. (NSP) reported mixed results for Q2 and H1 2026. In Q2 2026, total revenue increased 2% YoY to $1,686M, and the company returned to profitability with net income of $4M versus a net loss of -$5M in Q2 2025. However, gross profit declined 3% YoY to $217M in Q2, and for the first half of 2026 net income fell 20% to $37M from $46M in H1 2025. Operating cash flow remained negative at -$19M for H1 2026, though it improved significantly from -$522M in H1 2025.

• · Q2 2026 operating income was $6M compared to an operating loss of -$7M in Q2 2025.
• · H1 2026 operating income decreased to $68M from $61M in H1 2025.
• · Northeast segment revenue declined 1% YoY in both Q2 and H1 2026.
• · Other revenue (non-worksite employee) declined 12% YoY in Q2 and 11% in H1.
• · Dividends paid totaled $46M in H1 2026, up slightly from $45M in H1 2025.
• · Working capital (total current assets minus total current liabilities) improved to $180M at June 30, 2026, from $102M at December 31, 2025.

30-07-2026

PROG Holdings reported mixed Q2 2026 results. Total revenues increased 22.3% YoY to $719.7M, driven by new product and service revenues ($128.5M) from the recent acquisition. However, core lease revenues and fees declined 3.5% YoY to $549.8M. Net earnings from continuing operations were essentially flat at $37.4M vs $37.6M in Q2 2025, while total net earnings (including discontinued ops) decreased 3.8% to $37.0M. The company completed a significant acquisition, adding $391.8M in net cash outflow and substantially increasing goodwill and intangibles to $763.1M.

• · Provision for credit losses surged to $30.7M in Q2 2026 from $8.0M in Q2 2025, a 281% increase.
• · Cash provided by operating activities was $277.9M in H1 2026, nearly flat vs $279.8M in H1 2025.
• · The company repurchased $10.2M in treasury stock during H1 2026, down from $51.8M in H1 2025.
• · Dividends paid increased to $11.2M in H1 2026 from $10.4M in H1 2025.
• · Interest expense rose to $15.2M in Q2 2026 from $9.8M in Q2 2025, a 55.4% increase.
• · Depreciation of lease merchandise decreased to $364.3M in Q2 2026 from $385.1M in Q2 2025, a 5.4% decline.
• · Gain on sale of lease receivables was $4.7M in Q2 2026 vs $0 in Q2 2025.
• · Gain on change in fair value of receivables was $1.8M in Q2 2026 vs $0 in Q2 2025.

30-07-2026

NorthWestern Energy Group reported mixed results for Q2 2026. Total revenues increased 14.6% YoY to $392.6M, driven by higher electric and gas revenues, and net income rose 17.7% to $25.0M. However, for the first half of 2026, net income declined 9.9% to $88.5M compared to the prior year period, as operating income fell 3.9% due to higher operating expenses outpacing revenue growth.

• · Total operating expenses for H1 2026 increased 14.1% YoY to $711.8M, outpacing the 10.0% revenue growth.
• · Interest expense, net increased 11.2% YoY in Q2 2026 and 10.3% YoY in H1 2026, reflecting higher debt levels.
• · Cash and cash equivalents decreased from $8.8M at Dec 31, 2025 to $4.2M at June 30, 2026.
• · The company issued $375M in long-term debt during H1 2026, while repaying $60M in long-term debt and $50M in short-term borrowings.
• · Capital expenditures (PP&E additions) surged 37.9% YoY to $304.8M in H1 2026.
• · Dividends declared per common share increased 1.5% to $0.67 in Q2 2026 from $0.66 in Q2 2025.

30-07-2026

Hippo Holdings reported a strong turnaround in Q2 2026, with net income attributable to Hippo of $10.1M for the quarter (vs. $1.3M in Q2 2025) and $17.2M for the first half (vs. a loss of $46.4M in H1 2025). Revenue grew 23.4% YoY to $144.7M in Q2, driven by a 26.3% increase in net earned premium to $118.7M. However, the company recorded an unrealized loss on investments of $3.8M for the six-month period (vs. a gain of $2.8M in the prior year), and total assets grew to $2.32B from $1.91B at year-end 2025.

• · Net income per share (basic) was $0.38 for Q2 2026 vs. $0.05 in Q2 2025; for H1 2026 it was $0.66 vs. ($1.84) in H1 2025.
• · Total investments grew to $498.0M at June 30, 2026 from $445.9M at December 31, 2025.
• · Loss and loss adjustment expense reserve increased to $548.9M from $420.4M at year-end 2025.
• · Unearned premiums rose to $741.0M from $579.7M at December 31, 2025.
• · Sales and marketing expenses decreased to $6.3M in Q2 2026 from $9.2M in Q2 2025, a 31.5% reduction.
• · Technology and development expenses increased to $10.1M in Q2 2026 from $8.1M in Q2 2025.
• · No impairment and restructuring charges were recorded in 2026, compared to $1.2M in Q2 2025.
• · Net cash provided by investing activities was negative $34.7M in H1 2026 vs. negative $32.9M in H1 2025.
• · Net cash provided by financing activities was $4.6M in H1 2026 vs. $36.8M in H1 2025, primarily due to the absence of surplus note proceeds.
• · Intangible assets, net, decreased slightly to $13.4M from $13.8M at year-end 2025.

30-07-2026

Titan International reported a net loss attributable to common shareholders of $18.45M for the six months ended June 30, 2026, compared to a net loss of $5.194M in the prior year period, driven by $25.976M in restructuring and impairment expenses. Net sales increased 4.0% to $989.839M for the six-month period, while gross profit rose 6.1% to $146.373M. However, the company swung to an operating loss of $0.471M for the six months from an operating income of $21.959M a year ago, and cash flow from operations remained negative at -$7.377M.

• · Restructuring and impairment expenses of $25.976M in the six months ended June 30, 2026 (none in prior year) drove the operating loss.
• · Net cash used for operating activities improved to -$7.377M from -$24.278M in the prior year period.
• · Capital expenditures were $26.005M for the six months ended June 30, 2026, slightly up from $25.121M a year ago.
• · Long-term debt decreased slightly to $558.85M from $564.717M at year-end 2025.
• · Accounts receivable increased to $317.216M (net) from $238.906M at December 31, 2025, a 32.8% rise.
• · Inventories rose to $479.993M from $470.549M at year-end 2025.
• · The company had a net loss of $17.91M for the six months, compared to a net loss of $3.582M in the prior year.
• · Basic and diluted EPS for the six months was -$0.29, compared to -$0.08 in the prior year.

30-07-2026

NextDecade Corp reported a net loss attributable to common stockholders of $65.4M for Q2 2026, widening from $60.9M in Q2 2025, and $201.8M for H1 2026 vs $149.7M in H1 2025. The company continues to invest heavily in its Rio Grande LNG facility, with property, plant and equipment reaching $13.5B as of June 30, 2026, up from $10.6B at year-end 2025. Cash and restricted cash declined to $499.6M from $707.1M at the start of the period, while total debt increased to $10.4B from $8.5B. The company remains pre-revenue with no revenues reported for any period.

• · The company has no revenue for any period presented.
• · Net cash used in operating activities was $128.0M in H1 2026, up from $72.7M in H1 2025.
• · Capital expenditures (acquisition of property, plant and equipment) totaled $2.2B in H1 2026, compared to $1.5B in H1 2025.
• · Total equity increased to $2.8B as of June 30, 2026 from $2.3B at year-end 2025, driven by non-controlling interests.
• · Stockholders' equity turned negative to ($57.3M) as of June 30, 2026 from positive $95.3M at December 31, 2025.
• · Derivative gain (loss), net swung to a gain of $54.0M in H1 2026 from a loss of $143.5M in H1 2025.
• · Interest expense increased to $170.0M in H1 2026 from $58.8M in H1 2025.
• · Loss on debt extinguishment was $32.5M in H1 2026 vs $9.2M in H1 2025.
• · Finance lease right-of-use assets of $434.1M were recognized in H1 2026, with no comparable amount in prior period.

30-07-2026

Moelis & Company reported Q2 2026 revenue of $409.4M, up 12.0% YoY from $365.4M, and net income attributable to the company of $48.6M, up 17.0% from $41.5M. However, for the first half of 2026, net income attributable to Moelis fell 5.2% to $87.0M from $91.8M in H1 2025, and operating cash flow turned sharply negative at -$49.3M versus +$38.7M a year earlier, driven by a large decline in compensation payable.

• · Total assets decreased 19.1% from $1.74B at Dec 2025 to $1.41B at Jun 2026.
• · Total equity decreased 5.7% from $680.4M to $641.6M.
• · Compensation payable dropped 56.9% from $439.4M to $189.4M, driving the negative operating cash flow.
• · The company spent $140.8M on treasury stock purchases in H1 2026, up from $13.3M in H1 2025.
• · Dividends declared of $0.65 per share of Class A common stock in both Q1 and Q2 2026.
• · Diluted EPS for Q2 2026 was $0.62, up from $0.53 in Q2 2025; for H1 2026 it was $1.10, down from $1.17 in H1 2025.
• · Equity-based compensation was $117.7M in H1 2026 vs $127.8M in H1 2025, a decrease of 7.9%.

30-07-2026

Robinhood Markets reported strong financial results for Q2 2026, with total net revenues of $1,308M for the three months ended June 30, 2026, up 32% from $989M in the same period last year. Net income attributable to Robinhood was $561M ($0.62 per diluted share) compared to $386M ($0.42 per diluted share) in Q2 2025. However, the company experienced a foreign currency translation loss of $12M in Q2 2026 versus a gain of $7M in Q2 2025, and operating expenses increased 33% to $734M, driven by higher general and administrative costs and provision for credit losses.

• · Transaction-based revenues were $776M in Q2 2026, up from $539M in Q2 2025.
• · Net interest revenues were $389M in Q2 2026, up from $357M in Q2 2025.
• · Other revenues were $143M in Q2 2026, up from $93M in Q2 2025.
• · Cash and cash equivalents were $5,362M as of June 30, 2026, up from $4,261M as of December 31, 2025.
• · Goodwill increased to $516M as of June 30, 2026 from $385M as of December 31, 2025, reflecting acquisitions.
• · Intangible assets, net increased to $246M as of June 30, 2026 from $168M as of December 31, 2025.
• · Long-term borrowings were $2,170M as of June 30, 2026, compared to $0 as of December 31, 2025, due to the issuance of Convertible Notes.
• · Accumulated deficit improved to $(1,241)M as of June 30, 2026 from $(2,152)M as of December 31, 2025.
• · Net cash provided by operating activities was $2,758M for H1 2026, down from $4,151M for H1 2025.
• · Net cash used in investing activities was $1,054M for H1 2026, compared to net cash provided of $841M for H1 2025.
• · Net cash provided by financing activities was $2,086M for H1 2026, compared to net cash used of $703M for H1 2025.
• · The company recognized a gain on deconsolidation of RVI of $106M in H1 2026.
• · Share-based compensation was $197M for H1 2026, up from $151M for H1 2025.
• · The company purchased $228M of non-marketable securities in H1 2026, up from $8M in H1 2025.
• · The company repurchased $664M of Class A common stock in H1 2026, up from $446M in H1 2025.

30-07-2026

Escalade Inc. reported strong financial results for Q2 and H1 2026, with net sales rising 6.2% YoY to $57.7M in Q2 and 3.3% to $113.5M in H1. Operating income surged to $11.9M (Q2) and $17.8M (H1), driven by a $9.9M tariff recovery in Q2 2026. Net income jumped to $9.4M (Q2) and $13.8M (H1), compared to $1.8M and $4.4M in the prior-year periods. However, the Mass Merchants channel declined 3.6% in Q2 and 8.1% in H1, and International sales fell 10.4% in H1, indicating mixed performance across channels.

• · The company recorded a $9.9M tariff recovery in Q2 2026, which significantly boosted operating income.
• · Cost of products sold increased 4.1% YoY in Q2 but decreased 0.4% YoY in H1 2026.
• · Selling, administrative and general expenses rose 21.7% YoY in Q2 and 11.5% YoY in H1.
• · Interest income of $426K in Q2 2026 and $500K in H1 2026 was recorded, compared to zero in the prior-year periods.
• · The effective tax rate for Q2 2026 was 22.7% vs 25.8% in Q2 2025; for H1 2026 it was 23.0% vs 24.7% in H1 2025.
• · Net cash provided by operating activities decreased 13.3% YoY to $14.8M in H1 2026 from $17.1M in H1 2025.
• · Capital expenditures increased 32.2% YoY to $1.3M in H1 2026.
• · The company reduced long-term debt by $4.1M in H1 2026, ending with no long-term debt (all debt classified as current).
• · Dividends paid increased slightly to $4.2M in H1 2026 from $4.1M in H1 2025.
• · Stock repurchases totaled $1.3M in H1 2026, down from $2.2M in H1 2025.

30-07-2026

CSW Industrials, Inc. reported strong Q1 FY26 results for the three months ended June 30, 2026, with net revenues increasing 33% YoY to $350.7M and net income attributable to CSW rising 21.6% to $49.8M. The growth was driven by recent acquisitions, including the fiscal 2025 acquisition of $658.1M in net assets. However, the company saw a significant increase in interest expense (up 12.5x to $12.7M) and a decline in other income, while cash flow from operations improved 24.7% to $75.6M.

• · The company repurchased $23.5M of common shares during Q1 FY26, up from $4.7M in Q1 FY25.
• · Dividends paid were $4.9M in Q1 FY26 vs $4.5M in Q1 FY25.
• · Goodwill increased to $640.3M from $632.6M at March 31, 2026, primarily due to acquisition-related adjustments.
• · Total assets grew to $2.33B from $2.32B at March 31, 2026.
• · Long-term debt decreased slightly to $826.0M from $839.8M at March 31, 2026.
• · The company had $47.5M in cash at quarter end, up from $33.8M at March 31, 2026.
• · Accounts receivable increased 10.9% QoQ to $233.3M, while inventories declined 1.5% QoQ to $305.2M.
• · The fiscal 2025 acquisition purchase price was adjusted to $658.1M from an initial $667.5M, with goodwill adjusted to $259.5M.
• · Cash flow from operations improved to $75.6M from $60.6M in the prior year quarter.
• · Capital expenditures were $6.0M in Q1 FY26, up from $2.9M in Q1 FY25.

30-07-2026

Blackstone Mortgage Trust (BXMT) reported a net loss attributable to the company of $81.2 million for Q2 2026 and $87.5 million for H1 2026, compared to net income of $7.0 million and $6.6 million in the same periods of 2025. Total net revenue increased 18% YoY to $158.1 million in Q2, driven by a surge in owned real estate revenue ($75.5M vs $38.8M). However, the company recorded a $134.4 million increase in its credit loss reserve during Q2 (vs $45.6M a year ago), and net interest income from loans fell 13% to $82.6 million. Total assets declined 3% to $19.4 billion from $20.0 billion at year-end 2025, while stockholders' equity fell 7% to $3.26 billion.

• · Dividends declared on common stock were $0.47 per share in both Q1 and Q2 2026, totaling $79.4M and $79.4M respectively.
• · The company repurchased $3.8M of Class A common stock during H1 2026, down from $31.7M in H1 2025.
• · Weighted-average maximum maturity of loans was 2.8 years as of June 30, 2026, up from 2.5 years at year-end 2025.
• · Net cash provided by operating activities was $234.9M in H1 2026, up from $157.7M in H1 2025.
• · The company transferred $180.4M of senior loans to owned real estate during H1 2026 (non-cash), compared to $34.7M in H1 2025.
• · Unfunded loan commitments stood at $1.11B as of June 30, 2026, down from $1.19B at December 31, 2025.

30-07-2026

Cinemark Holdings reported strong Q2 2026 results with total revenue of $1,086.4M, up 15.5% from $940.5M in Q2 2025, driven by admissions (+15.6%) and concession (+14.7%) growth. Net income attributable to Cinemark rose to $139.4M from $93.5M, and basic EPS improved to $1.20 from $0.81. However, the company continued to repurchase shares ($25.3M in Q2) and increased its dividend to $0.09 per share, while cash flow from operations more than doubled to $339.7M for the first half. On the balance sheet, retained earnings turned positive at $47.1M versus a deficit of $64.4M at year-end 2025, but total debt remained high at $1,876.8M (including current portion).

• · Retained earnings turned positive to $47.1M at June 30, 2026 from a deficit of $64.4M at December 31, 2025.
• · Total debt remained essentially flat at $1,876.8M (June 30, 2026) vs $1,875.6M (Dec 31, 2025).
• · Capital expenditures increased to $99.3M in H1 2026 from $52.2M in H1 2025.
• · The company paid dividends of $0.09 per share in Q2 2026, up from $0.08 in Q2 2025.
• · Share repurchases in Q2 2026 were $25.3M, significantly lower than the $200.0M repurchased in H1 2025.
• · Operating cash flow for H1 2026 was $339.7M, more than double the $156.8M in H1 2025.
• · Interest expense decreased to $31.3M in Q2 2026 from $39.4M in Q2 2025.
• · Impairment of long-lived assets was zero in Q2 2026 vs $1.6M in Q2 2025.

30-07-2026

Phathom Pharmaceuticals reported strong revenue growth for Q2 2026, with product revenue more than doubling year-over-year to $74.3M, driven by increased sales of its lead product. However, the company remains unprofitable, posting a net loss of $17.6M for the quarter, though this is a significant improvement from the $75.8M loss in Q2 2025. The company strengthened its balance sheet through a public offering and debt restructuring, ending the quarter with $182.5M in cash and cash equivalents.

• · Gross profit for Q2 2026 was $59.2M, up from $34.5M in Q2 2025.
• · Selling, general and administrative expenses decreased to $55.3M in Q2 2026 from $85.3M in Q2 2025, a 35% reduction.
• · Research and development expenses were $7.8M in Q2 2026, down from $9.1M in Q2 2025.
• · Net cash used in operating activities improved to $17.6M in H1 2026 from $147.7M in H1 2025.
• · The company had an accumulated deficit of $1.53B as of June 30, 2026.
• · Total stockholders' deficit improved to $(344.3M) from $(438.2M) at year-end 2025.
• · Accounts receivable increased to $97.4M from $78.1M, reflecting higher sales.
• · Accrued revenue allowances rose to $87.7M from $65.5M, likely tied to rebates and chargebacks.

30-07-2026

Laureate Education reported strong financial results for the three and six months ended June 30, 2026. Revenues for Q2 2026 increased 17.5% YoY to $615.9M, and net income attributable to Laureate rose 44.2% to $137.1M. For the six-month period, revenues grew 16.9% to $888.5M and net income increased 52.8% to $115.5M. However, comprehensive income attributable to Laureate declined 2.4% for the quarter and 17.3% for the six-month period, driven by a significantly smaller foreign currency translation gain.

• · Foreign currency exchange loss improved significantly: Q2 2026 loss of $2.0M vs $25.6M in Q2 2025; H1 2026 loss of $1.0M vs $28.8M in H1 2025.
• · Operating income grew 15.6% YoY in Q2 2026 to $223.4M and 8.7% in H1 2026 to $195.9M.
• · Income tax expense increased 17.7% in Q2 and 5.7% in H1, reflecting higher pre-tax income.
• · No discontinued operations in 2026; minimal in prior periods.
• · Total assets increased 9.8% from Dec 31, 2025 to $2.42B, driven by growth in receivables, operating lease right-of-use assets, and goodwill.
• · Allowance for doubtful accounts remained high at $128.3M (44.9% of gross receivables) at June 30, 2026, up from $125.1M (48.2% of gross receivables) at Dec 31, 2025.

30-07-2026

PBF Energy reported strong quarter-to-quarter and year-over-year improvements: revenue for the three months ended June 30, 2026 increased to $11,678.3 from $7,475.3 in Q2 2025 (+56.2%), and six-month revenue rose to $19,582.6 from $14,541.7 (+34.7%). However, while net income attributable to PBF Energy Inc. stockholders turned positive to $906.4 for the quarter (versus a loss of $(5.2) in Q2 2025) and $1,104.7 for the six months (versus a loss of $(407.0)), certain cost lines remain elevated and long-term debt declined but deferred tax liabilities increased materially, indicating mixed operational and balance-sheet dynamics.

• · Gain on insurance recoveries, net increased to (250.0) for the three months ended June 30, 2026 from (189.0) in Q2 2025 (i.e., larger benefit).
• · Equity (income) loss in investee shows income of (27.5) in Q2 2026 versus expense of 4.3 in Q2 2025 (favorable swing).
• · Deferred tax liabilities rose to $1,040.5 at June 30, 2026 from $763.6 at December 31, 2025 (increase of 36.3%).
• · Company issued $500.0 of 2034 7.25% Senior Notes and redeemed $801.6 of 2028 6.00% Senior Notes in the six months ended June 30, 2026.
• · Net cash provided by operating activities swung to $1,265.1 in six months 2026 from $(470.3) in six months 2025 (material improvement).
• · Capital expenditures: $476.5 for property, plant and equipment and $242.4 for deferred turnaround costs in six months 2026 (both increased vs prior period).

30-07-2026

Life Time Group Holdings, Inc. reported strong financial results for Q2 2026, with total revenue increasing 13.7% YoY to $866.0M and net income rising 40.6% to $101.4M. For the first half of 2026, revenue grew 12.8% to $1,654.7M and net income increased 27.8% to $189.5M. However, the company experienced a foreign currency translation loss of $1.6M in Q2 2026 (vs a gain of $3.9M in Q2 2025), and equity in affiliates swung to a loss of $2.7M from a small gain. Operating cash flow increased 7.6% to $408.4M in H1 2026, but capital expenditures surged 43.6% to $523.3M, leading to negative free cash flow.

• · Interest expense net of interest income decreased 20.1% YoY in Q2 2026 to $17.4M from $21.8M.
• · Provision for income taxes in H1 2026 was $64.3M, up 89.9% from $33.9M in H1 2025.
• · The company repurchased $73.4M of common stock in H1 2026, compared to zero in H1 2025.
• · Proceeds from sale-leaseback transactions were $200.2M in H1 2026, up from $138.8M in H1 2025.
• · Cash and cash equivalents and restricted cash were $258.2M at June 30, 2026, up from $196.2M a year earlier.
• · Total equity increased to $3,302.2M at June 30, 2026 from $2,869.2M at June 30, 2025.
• · The company had $9.2M in interest rate swap assets (Level 2) at June 30, 2026.
• · Deferred compensation liabilities of $18.4M (Level 1) were recorded at June 30, 2026.

30-07-2026

Regeneron Pharmaceuticals reported mixed results for the second quarter and first half of 2026. Total revenues for Q2 2026 increased 16.7% YoY to $4,290.7M, driven by a 32.0% surge in collaboration revenue to $2,455.0M. However, net income for Q2 2026 declined 6.8% YoY to $1,296.9M, and for the six-month period net income fell 8.0% to $2,024.1M, as operating expenses grew faster than revenue. The company continued aggressive share repurchases, spending $1,963.7M in the first half of 2026, while cash and equivalents decreased to $2,455.8M from $3,118.1M at year-end 2025.

• · Net product sales were essentially flat in Q2 2026 at $1,642.4M vs $1,631.0M in Q2 2025, a 0.7% increase.
• · Acquired in-process R&D expenses surged to $127.0M in Q2 2026 from $10.0M in Q2 2025, a 1,170% increase.
• · Income tax expense rose 81.7% in Q2 2026 to $230.9M from $127.1M in Q2 2025.
• · Diluted EPS declined 4.5% in Q2 2026 to $12.23 from $12.81 in Q2 2025.
• · Cash flow from operations decreased 13.6% in the first half of 2026 to $1,891.9M from $2,189.5M in the prior year period.
• · Accounts receivable increased by $837.3M in the first half of 2026, a significant cash outflow vs an inflow of $629.6M in the prior year period.
• · The company's accumulated other comprehensive income swung from a gain of $77.5M at Dec 31, 2025 to a loss of $35.8M at June 30, 2026.
• · Regeneron's share of profits from the Sanofi collaboration was $2,032.6M in Q2 2026, up 58.5% from $1,282.1M in Q2 2025.
• · The company has not yet adopted ASU 2024-03 on disaggregated income statement expenses, effective for annual periods beginning January 1, 2027.

30-07-2026

Bridgewater Bancshares Inc reported strong Q2 2026 results with net income of $14.0M, up 21.6% YoY from $11.5M, driven by a 18.8% increase in net interest income to $38.6M. However, noninterest income declined 35.9% YoY to $2.3M, primarily due to the absence of securities gains and lower swap fees, while noninterest expense rose 15.6% to $21.9M. For the six-month period, net income available to common shareholders surged 53.6% to $29.4M, with diluted EPS of $1.03 versus $0.68 in the prior year.

• · Interest expense on deposits decreased 8.6% YoY to $29.7M in Q2 2026 from $32.5M in Q2 2025.
• · Salaries and employee benefits increased 22.5% YoY to $13.9M in Q2 2026.
• · Net gain on sales of securities was $7.3M in H1 2026 vs $0.5M in H1 2025, but Q2 2026 had zero securities gains.
• · FHLB advances decreased to $326.0M at June 30, 2026 from $399.5M at December 31, 2025.
• · Allowance for credit losses on loans increased to $57.4M at June 30, 2026 from $56.4M at December 31, 2025.
• · Accumulated other comprehensive income swung from a gain of $0.6M at Dec 2025 to a loss of $0.6M at June 2026.
• · Net cash provided by operating activities more than doubled to $25.9M in H1 2026 from $10.7M in H1 2025.
• · Stock repurchases totaled $0.7M in H1 2026, down from $2.2M in H1 2025.

30-07-2026

Tradeweb Markets Inc. reported strong financial results for Q2 and H1 2026, with total revenue increasing 9.0% YoY to $558.9M in Q2 and 15.1% YoY to $1.18B in H1. Net income attributable to Tradeweb rose 17.9% YoY to $181.3M in Q2 and 27.9% YoY to $386.6M in H1. However, the company saw a decline in cash and cash equivalents from $2.08B at year-end 2025 to $2.06B at June 30, 2026, driven by significant share repurchases ($240.5M in H1) and increased investing activities ($111.2M).

• · Transaction fees and commissions revenue grew 8.3% YoY to $465.3M in Q2 and 16.2% YoY to $989.2M in H1.
• · Subscription fees increased 7.5% YoY to $61.7M in Q2 and 7.8% YoY to $122.0M in H1.
• · LSEG market data fees rose 28.8% YoY to $26.5M in Q2 and 7.6% YoY to $53.2M in H1.
• · Employee compensation and benefits expense increased 1.6% YoY to $172.5M in Q2 and 6.8% YoY to $370.3M in H1.
• · Technology and communications expense surged 38.9% YoY to $42.0M in Q2 and 38.3% YoY to $81.5M in H1.
• · General and administrative expense declined 44.6% YoY to $16.6M in Q2 and 42.6% YoY to $28.6M in H1.
• · Depreciation and amortization expense decreased 2.5% YoY to $61.5M in Q2 and 2.8% YoY to $122.2M in H1.
• · Goodwill remained unchanged at $3.15B.
• · Intangible assets, net decreased 5.1% from $1.15B at Dec 31, 2025 to $1.09B at Jun 30, 2026.
• · Total liabilities decreased 8.8% from $1.00B at Dec 31, 2025 to $912.7M at Jun 30, 2026.
• · Dividends paid totaled $59.5M in H1 2026, up 16.3% from $51.2M in H1 2025.
• · Income taxes paid increased significantly to $112.9M in H1 2026 from $45.1M in H1 2025.

30-07-2026

Madison Air Solutions Corp (MAIR) reported strong Q2 FY26 results with net sales of $991.3M, up 20.9% YoY, and adjusted net income of $147.7M, up 70.8% YoY. However, organic revenue growth slowed to 14.1% from 14.6% in the prior-year quarter, and the Residential segment posted a 4.8% organic revenue decline. Free cash flow fell to $140.0M from $152.4M in the first half of the year.

• · Loss on extinguishment of debt of $27.7M in Q2 FY26.
• · Write-off of deferred tax asset of $13.7M in Q2 FY26.
• · Equity appreciation rights expense of $16.3M in Q2 FY26, down from $22.1M in Q2 FY25.
• · Transaction related expenses were a net credit of $0.8M in Q2 FY26 vs. expense of $17.9M in Q2 FY25.
• · Operating cash flow conversion from continuing operations fell to 137.8% in H1 FY26 from 211.1% in H1 FY25.
• · Net cash used in investing activities was $17.0M in H1 FY26 vs. $2,312.6M in H1 FY25 (prior year included large acquisition).
• · Net cash provided by financing activities was negative $86.3M in H1 FY26 vs. positive $1,958.9M in H1 FY25.

30-07-2026

Bicycle Therapeutics reported a net loss of $50.3M for Q2 2026, narrowing from a $79.0M loss in Q2 2025, driven by a 38% reduction in R&D expenses to $41.2M. However, collaboration revenue fell sharply by 78% to $0.6M from $2.9M a year ago, with no revenue from Novartis or Genentech in the quarter. Cash and cash equivalents decreased to $510.1M from $628.1M at year-end 2025, reflecting ongoing cash burn.

• · Accumulated deficit grew to $1.01B at June 30, 2026 from $899.8M at December 31, 2025.
• · Net cash used in operating activities improved to $115.5M in H1 2026 from $159.2M in H1 2025.
• · Share-based compensation expense was $13.3M in H1 2026, down from $19.0M in H1 2025.
• · Deferred revenue from Bayer collaboration was $33.2M at June 30, 2026, down from $34.6M at year-end 2025.
• · Ionis collaboration deferred revenue was $3.8M at June 30, 2026, essentially flat from $3.8M at year-end 2025.
• · Total liabilities decreased to $96.3M from $107.6M at December 31, 2025.
• · Weighted average shares outstanding increased slightly to 69.8M in Q2 2026 from 69.3M in Q2 2025.

30-07-2026

Myers Industries Inc. reported strong Q2 2026 results with net sales of $179.2M, up 9.8% YoY from $163.2M, and net income of $20.0M, more than doubling from $9.7M in Q2 2025. Operating income surged 57.1% to $31.2M, driven by improved gross margins (34.3% vs 31.3%). However, for the six-month period, net income was only $18.2M, held back by a $14.3M loss from discontinued operations, and cash flow from operations improved significantly to $59.7M from $38.4M.

• · Q2 2026 gross profit margin improved to 34.3% from 31.3% in Q2 2025.
• · SG&A expenses decreased 2.9% YoY in Q2 2026 to $26.6M.
• · Interest expense declined 14.9% YoY to $6.3M in Q2 2026.
• · H1 2026 loss from discontinued operations was $14.3M, compared to a $0.3M loss in H1 2025.
• · Cash flow from operations (continuing) for H1 2026 was $58.8M, up 55.1% from $37.9M in H1 2025.
• · Capital expenditures decreased to $8.4M in H1 2026 from $11.6M in H1 2025.
• · The company reduced long-term debt by $38.8M during H1 2026, from $311.2M to $272.4M.
• · Dividends declared were $0.135 per share in Q2 2026, unchanged from Q2 2025.
• · No share repurchases occurred in H1 2026, compared to $1.5M in H1 2025.
• · Assets held for sale (current) increased to $68.4M at June 30, 2026 from $55.9M at December 31, 2025, indicating ongoing divestiture activity.

30-07-2026

Altria Group reported net revenues of $11,539M for the six months ended June 30, 2026, up 1.6% from $11,361M in the prior year period, while net earnings increased 29.7% to $4,481M from $3,455M, partly due to the absence of a $873M goodwill impairment charge in the prior year. However, for the three months ended June 30, 2026, net revenues were essentially flat at $6,111M versus $6,102M, and net earnings declined 3.4% to $2,298M from $2,378M, with basic EPS falling to $1.37 from $1.41. The company's total stockholders' deficit improved to ($2,618M) from ($3,452M) at year-end 2025, but cash and cash equivalents dropped sharply to $2,367M from $4,474M.

• · Operating income for six months ended June 30, 2026 was $6,092M, up 21.4% from $5,018M in the prior year period, but for Q2 2026 it declined 2.9% to $3,136M from $3,230M.
• · Gross profit for six months increased 3.2% to $7,326M from $7,099M, but Q2 gross profit fell 0.8% to $3,820M from $3,850M.
• · Excise taxes on products decreased 8.2% for six months to $1,425M from $1,552M, and 7.0% for Q2 to $755M from $812M.
• · Marketing, administration and research costs increased 0.5% for six months to $1,213M from $1,207M, and rose 7.1% for Q2 to $663M from $619M.
• · Interest and other debt expense, net increased 3.0% for six months to $553M from $537M, and 7.3% for Q2 to $295M from $275M.
• · Income from investments in equity securities decreased 15.8% for six months to $245M from $291M, and 41.2% for Q2 to $87M from $148M.
• · Provision for income taxes decreased 2.9% for six months to $1,307M from $1,346M, and 14.7% for Q2 to $631M from $740M.
• · Comprehensive earnings for six months were $4,727M, up 56.3% from $3,024M, and for Q2 were $2,367M, up 5.8% from $2,238M.
• · Dividends payable decreased slightly to $1,777M from $1,782M at year-end 2025.
• · Settlement charges accrued liabilities dropped to $1,169M from $2,178M at December 31, 2025.

30-07-2026

ProPetro Holding Corp. reported a net loss of $8.1M for Q2 2026 and $11.8M for H1 2026, compared to a net loss of $7.2M and net income of $2.4M in the prior-year periods, respectively. Revenue declined 6.2% YoY in Q2 to $305.8M and 15.9% YoY in H1 to $576.5M, driven by lower service activity. However, the company strengthened its balance sheet significantly, ending the quarter with $784.0M in cash after raising $690.0M in convertible senior notes and $164.3M in a public equity offering, while long-term debt increased to $764.9M.

• · Operating loss remained essentially flat YoY in Q2 2026 at -$3.2M vs -$3.2M in Q2 2025.
• · Cost of services (excluding D&A) decreased 7.6% YoY in Q2 to $234.0M and 13.8% YoY in H1 to $445.7M.
• · Depreciation and amortization was nearly flat YoY in Q2 at $43.5M vs $43.3M, but decreased 8.6% in H1 to $84.1M from $92.0M.
• · Interest expense increased 66.0% YoY in Q2 to $3.0M and 60.1% in H1 to $5.7M, reflecting higher debt levels.
• · Net cash provided by operating activities declined 36.8% in H1 2026 to $68.8M from $108.9M in H1 2025.
• · Capital expenditures increased 34.2% in H1 2026 to $104.7M from $78.0M in H1 2025.
• · The company issued 17.25 million shares in a public equity offering during H1 2026, raising $164.3M in net proceeds.
• · Convertible senior notes of $690.0M were issued in H1 2026, with $36.8M used to purchase capped calls.
• · Total assets grew 59.6% from $1.29B at Dec 31, 2025 to $2.06B at Jun 30, 2026, primarily due to increased cash and debt-financed investments.
• · Shareholders' equity increased 15.4% to $957.4M from $829.8M, supported by the equity offering despite net losses.

30-07-2026

EMCOR Group reported strong Q2 2026 results with revenues of $5.15B, up 19.8% YoY, and net income of $403.7M, up 33.6% YoY. However, operating cash flow declined to $289.9M for the first half of 2026 from $302.2M in the prior year period, and the company's cash position fell to $924.4M from $1.11B at year-end 2025 due to significant share repurchases and acquisition spending.

• · Diluted EPS for Q2 2026 was $9.06, up from $6.72 in Q2 2025.
• · Dividends declared per common share increased to $0.40 in Q2 2026 from $0.25 in Q2 2025.
• · Total assets grew to $10.16B at June 30, 2026 from $9.29B at December 31, 2025.
• · Goodwill increased to $1.46B from $1.41B, reflecting acquisition activity.
• · The U.S. electrical construction segment's network and communications market sector revenue surged to $973.0M (58% of segment) from $670.0M (50%) in Q2 2025.
• · Healthcare market sector revenue in the segment declined to $116.2M from $133.7M YoY.
• · Transportation market sector revenue fell to $41.8M from $66.5M YoY.
• · Share repurchases totaled $265.3M in H1 2026, down from $423.3M in H1 2025.
• · Acquisition spending was $95.0M in H1 2026 versus $887.2M in H1 2025.

30-07-2026

Butterfly Network, Inc. reported a net loss of $12.9M for Q2 2026, narrower than the $13.8M loss in Q2 2025, as total revenue surged 39% to $32.6M. The strong top-line growth was driven by a 150% jump in software and other services revenue to $16.9M, while product revenue declined 5% to $15.7M. However, operating expenses rose 19% to $37.0M, and the company's cash position shrank 15% to $124.7M from year-end 2025.

• · Net cash used in operating activities worsened 60% to $30.2M in H1 2026 from $18.8M in H1 2025.
• · Accounts receivable increased to $34.6M at June 30, 2026 from $26.7M at Dec 31, 2025, a 29% rise.
• · Deferred revenue (current) fell sharply to $15.5M at June 30, 2026 from $26.9M at Dec 31, 2025.
• · Accumulated deficit grew to ($904.8M) from ($879.2M) at Dec 31, 2025.
• · Shares outstanding increased by 10.7 million Class A shares from Dec 31, 2025 to June 30, 2026, primarily due to stock option exercises and RSU vesting.

30-07-2026

FTI Consulting reported mixed results for Q2 2026. Revenue increased 5.3% YoY to $993.5M for the quarter and 7.3% to $1,976.8M for the six months. However, operating income declined 14.3% YoY to $85.0M (Q2) and 5.1% to $168.9M (H1), while net income fell 19.4% to $57.8M (Q2) and 13.5% to $115.4M (H1). The company significantly increased long-term debt to $1,019.3M (from $365.0M at year-end) and aggressively repurchased shares, reducing outstanding shares by 10.2% to 27.7 million.

• · Direct cost of revenues increased 5.6% YoY to $677.2M in Q2 2026 and 8.3% to $1,353.7M in H1 2026.
• · Selling, general and administrative expenses rose 14.1% YoY to $230.7M in Q2 2026 and 17.2% to $453.0M in H1 2026.
• · Interest expense more than doubled to $11.6M in Q2 2026 (from $5.3M) and nearly tripled to $18.1M in H1 2026 (from $6.2M).
• · Net cash used in operating activities improved to $157.7M in H1 2026 from $409.5M in H1 2025, driven by lower working capital outflows.
• · The company borrowed $1,085.0M and repaid $730.0M under its revolving credit facility in H1 2026, and also issued a $300.0M term loan.
• · Share repurchases totaled $520.0M in H1 2026, slightly down from $536.7M in H1 2025.
• · Stockholders' equity decreased 23.1% from $1,733.7M at Dec 31, 2025 to $1,334.0M at Jun 30, 2026, primarily due to share repurchases and retained earnings reduction.
• · Accumulated other comprehensive loss worsened to $(139.9)M from $(129.6)M, driven by negative foreign currency translation adjustments.
• · Allowance for expected credit losses increased to $107.9M from $104.7M at year-end 2025.
• · No special charges were recorded in H1 2026, compared to $25.3M in H1 2025.

30-07-2026

NewMarket Corp reported strong Q2 2026 results with net sales of $747.1M, up 7.0% YoY, and net income of $133.8M, up 20.2% YoY. For the six months, net sales were $1,416.8M (+1.2% YoY) and net income was $251.8M (+6.2% YoY). However, comprehensive income declined significantly in both periods due to unfavorable foreign currency translation adjustments, and the company continued aggressive share repurchases and increased dividends.

• · Operating profit for Q2 2026 was $163.7M, up 14.3% from $143.2M in Q2 2025.
• · Research, development, and testing expenses decreased 6.1% YoY in Q2 2026 to $30.4M.
• · Interest and financing expenses, net decreased 17.9% YoY in Q2 2026 to $8.8M.
• · Cash provided from operating activities for H1 2026 was $286.2M, up 1.7% from $281.4M in H1 2025.
• · Capital expenditures increased 76.6% to $51.7M in H1 2026 from $29.3M in H1 2025.
• · The company completed an acquisition with fair value of net assets acquired of $218M, including $171M in intangible assets (customer base $119M, formulas/technology $31M, backlog $20M, trademarks $1M).
• · Long-term debt decreased to $854.8M at June 30, 2026 from $883.4M at December 31, 2025.
• · Share repurchases accelerated: 204,927 shares repurchased in H1 2026 vs 133,658 in H1 2025.
• · Cash dividends declared per share increased 9.1% to $3.00 per quarter from $2.75.
• · Foreign currency translation adjustments were a negative $5.6M in H1 2026 vs a positive $39.8M in H1 2025.

30-07-2026

Disc Medicine, Inc. reported a net loss of $59.5M for Q2 2026, widening from a $55.2M loss in Q2 2025, driven by higher operating expenses. For the first half of 2026, the net loss was $123.0M versus $89.3M in the prior-year period. The company ended Q2 2026 with $717.7M in cash, cash equivalents, and marketable securities, down from $791.2M at year-end 2025, reflecting ongoing R&D investment and a $30.0M draw on long-term debt.

• · Net loss per share for Q2 2026 was $(1.54), improving from $(1.58) in Q2 2025, despite a larger net loss, due to a higher share count.
• · Net loss per share for H1 2026 was $(3.19), worsening from $(2.61) in H1 2025.
• · Cash used in operating activities for H1 2026 was $106.4M, up from $89.3M in H1 2025.
• · The company drew $30.0M in long-term debt during H1 2026, increasing total debt to $59.3M.
• · Stock-based compensation expense was $25.9M in H1 2026, up from $14.8M in H1 2025.
• · Accumulated other comprehensive income swung to a loss of $(1.6M) at June 30, 2026 from a gain of $1.0M at December 31, 2025, driven by unrealized losses on marketable securities.
• · No proceeds from equity offerings in H1 2026, compared to $243.4M in net proceeds from an underwritten offering in H1 2025.

30-07-2026

InterDigital reported a decline in revenue and net income for Q2 and H1 2026 compared to the same periods in 2025. Total revenue for Q2 2026 was $260.2M, down 13% YoY from $300.6M, while net income fell 36% to $116.4M from $180.6M. The declines were driven by a 48% drop in Smartphone segment revenue and a 58% drop in CE, IoT/Auto, partially offset by a new $110.0M Streaming and Cloud Services segment. Cash and cash equivalents decreased to $615.6M from $738.9M at year-end 2025, and the company continued share repurchases and increased dividends.

• · Operating expenses increased 27% in Q2 2026 to $120.9M from $95.2M in Q2 2025, driven by higher licensing and G&A costs.
• · Net cash provided by operating activities improved to $98.6M in H1 2026 from $85.1M in H1 2025.
• · The company repurchased $31.1M of common stock in H1 2026, similar to $31.4M in H1 2025.
• · Dividends paid increased to $36.1M in H1 2026 from $27.1M in H1 2025.
• · Current portion of long-term debt decreased to $378.2M from $458.4M at year-end 2025.
• · Deferred revenue (current) increased to $325.7M from $193.7M at year-end 2025.
• · Treasury stock cost increased to $2.15B from $1.83B at year-end 2025.
• · Diluted EPS for Q2 2026 was $3.40, down from $5.35 in Q2 2025.

30-07-2026

HF Sinclair Corp reported a strong Q2 2026 with net income attributable to stockholders of $892M ($4.93 per diluted share), a significant increase from $208M ($1.10 per diluted share) in Q2 2025. Revenue surged to $10,390M from $6,784M in the prior-year quarter, driven by higher sales volumes and improved margins. However, the company recorded a lower of cost or market inventory valuation adjustment of $30M in Q2 2026 (vs. $148M in Q2 2025) and a $642M benefit in the first half of 2026, reflecting volatile commodity prices. Cash flow from operations more than tripled to $1,967M in H1 2026, while the company continued share repurchases ($255M in H1) and paid dividends of $180M.

• · Lower of cost or market inventory valuation adjustment was a $30M charge in Q2 2026 vs. $148M charge in Q2 2025; for H1 2026 it was a $642M benefit vs. $31M charge in H1 2025.
• · Operating expenses increased to $654M in Q2 2026 from $572M in Q2 2025, a 14.3% rise.
• · Selling, general and administrative expenses rose to $130M in Q2 2026 from $114M in Q2 2025.
• · Depreciation and amortization was $228M in Q2 2026, essentially flat vs. $226M in Q2 2025.
• · Interest expense decreased significantly to $20M in Q2 2026 from $53M in Q2 2025, reflecting lower debt levels.
• · Capital expenditures (additions to properties, plants and equipment) were $220M in H1 2026 vs. $197M in H1 2025.
• · The company acquired $38M in assets, net of cash acquired, and invested $22M in an equity method investment during H1 2026.
• · Treasury stock repurchases totaled $255M in H1 2026 (including excise tax), compared to $50M in H1 2025.
• · Dividends declared were $0.50 per common share in Q2 2026, consistent with Q2 2025.
• · Accumulated other comprehensive loss worsened to $(46)M at June 30, 2026 from $(26)M at December 31, 2025, primarily due to foreign currency translation losses.

30-07-2026

Arxis, Inc. reported a net loss of $4.9 million for Q2 2026, compared to a net loss of $29.3 million in Q2 2025, while revenue grew 25% to $500.7 million. For the first half of 2026, net income was $48.4 million versus a net loss of $33.6 million in the prior year period. However, operating income declined sharply from $82.9 million to $32.7 million in Q2 due to a surge in SG&A expenses, and the company reported a net loss per share of $0.01.

• · The company completed an IPO in Q2 2026, issuing 46,575,000 shares of common stock for net proceeds of $1.2 billion.
• · Total debt decreased from $2.63 billion at December 31, 2025 to $1.72 billion at June 30, 2026, primarily due to repayments.
• · Cash and cash equivalents nearly doubled from $250.3 million to $494.7 million during H1 2026.
• · Share-based compensation expense surged to $102.1 million in H1 2026 from $4.5 million in H1 2025.
• · The company acquired businesses for $185.8 million in H1 2026, up from $152.6 million in H1 2025.
• · Net loss per share for Q2 2026 was $0.01 (basic and diluted).

30-07-2026

Vericel Corp reported a strong Q2 2026, swinging to a net income of $2.2M from a net loss of $0.6M in Q2 2025, driven by 22.5% revenue growth to $77.5M. However, for the first half of 2026, the company still recorded a net loss of $4.1M, though this was a significant improvement from an $11.8M loss in H1 2025. While gross profit margins improved, operating expenses grew 15.1% in Q2, and the company's accumulated deficit widened to $380.4M.

• · Cash provided by operating activities for H1 2026 was $32.6M, up from $14.8M in H1 2025.
• · Capital expenditures for H1 2026 were $3.2M, down sharply from $22.3M in H1 2025.
• · Stock-based compensation expense for H1 2026 was $20.4M, slightly down from $21.6M in H1 2025.
• · Accounts receivable decreased to $75.7M at June 30, 2026 from $84.6M at December 31, 2025.
• · The company had an accumulated other comprehensive loss of $0.4M at June 30, 2026 vs a gain of $0.3M at December 31, 2025.
• · Diluted EPS for Q2 2026 was $0.04 vs ($0.01) in Q2 2025.

30-07-2026

Sirius XM Holdings reported Q2 2026 revenue of $2,160M, up 1.0% YoY from $2,138M, and net income of $239M, up 16.6% YoY from $205M. For the six-month period, revenue grew 1.1% to $4,251M and net income rose 18.3% to $484M. However, equipment revenue declined 21.7% YoY in Q2 to $36M, and subscriber revenue growth remained modest at 0.6% YoY. The company reduced operating expenses by 4.8% in Q2, driven by lower impairment costs, while interest expense and other expenses increased, partially offsetting operating gains.

• · Q2 2026 subscriber revenue was $1,638M (flat growth of 0.6% YoY).
• · Q2 2026 equipment revenue declined 21.7% YoY to $36M.
• · Q2 2026 other expense (income) swung to a loss of $48M from a gain of $15M in Q2 2025.
• · Total comprehensive income for Q2 2026 was $231M, up from $201M in Q2 2025.
• · Long-term debt increased to $9,453M as of June 30, 2026, from $8,648M at December 31, 2025.
• · Cash and cash equivalents more than doubled to $174M from $94M at year-end 2025.
• · Dividends paid in Q2 2026 were $91M, up from $84M in Q2 2025.
• · Share repurchases in Q2 2026 were $6M, significantly lower than $45M in Q2 2025.
• · Impairment, restructuring and other costs dropped sharply to $6M in Q2 2026 from $107M in Q2 2025.
• · General and administrative expenses decreased 18.1% YoY to $136M in Q2 2026.

30-07-2026

Teladoc Health reported Q2 2026 revenue of $606.9M, down 4.0% YoY from $631.9M, with net loss widening to $38.9M from $32.7M. For H1 2026, revenue declined 3.2% to $1.22B, while net loss improved to $102.7M from $125.7M. Access Fees revenue fell 9.5% in Q2, but Other revenue grew 22.7%. Operating loss narrowed to $37.1M from $54.4M in Q2, and cash from operations decreased to $74.2M from $107.4M in H1.

• · Q2 2026 operating loss improved to $37.1M from $54.4M in Q2 2025.
• · H1 2026 operating loss improved to $98.9M from $175.0M in H1 2025.
• · Q2 2026 net loss per share was $0.21, compared to $0.19 in Q2 2025.
• · H1 2026 net loss per share was $0.57, compared to $0.72 in H1 2025.
• · Total assets decreased to $2.76B from $2.86B at Dec 31, 2025.
• · Goodwill remained unchanged at $283.2M.
• · Intangible assets, net decreased to $1.18B from $1.30B.
• · Convertible senior notes of $996.7M reclassified to current from non-current.
• · Accumulated deficit increased to $16.53B from $16.43B.
• · U.S. revenue declined 6.2% in Q2 2026 to $487.4M from $519.7M.
• · International revenue grew 6.6% in Q2 2026 to $119.6M from $112.2M.
• · Cash used in investing activities was $78.1M in H1 2026, down from $183.0M in H1 2025.
• · No acquisitions or goodwill impairment in H1 2026, compared to $65.3M acquisitions and $59.1M goodwill impairment in H1 2025.

30-07-2026

Quanta Services reported strong financial results for Q2 2026, with revenues of $9.56B (up 41.1% YoY) and net income attributable to common stock of $451.4M (up 96.9% YoY). For the six months ended June 30, 2026, revenues were $17.43B (up 34.0% YoY) and net income was $672.0M (up 79.9% YoY). However, the company experienced a foreign currency translation loss of $22.1M in Q2 2026 (vs. a gain of $73.8M in Q2 2025), and operating cash flow was heavily impacted by a $1.13B increase in accounts receivable.

• · Total assets increased to $28.29B at June 30, 2026 from $24.93B at December 31, 2025.
• · Total liabilities increased to $18.55B from $15.90B over the same period.
• · Goodwill increased to $7.87B from $7.32B, reflecting acquisition activity.
• · The company paid $33.7M in dividends in H1 2026, up from $30.3M in H1 2025.
• · No common stock repurchases were made in H1 2026, compared to $134.6M in H1 2025.
• · Cash paid for acquisitions in H1 2026 was $930.3M, up from $586.1M in H1 2025.
• · Accounts receivable increased by $1.69B (24.6%) from December 31, 2025 to June 30, 2026.
• · Contract liabilities increased to $4.24B from $3.26B, indicating strong backlog.

30-07-2026

Agios Pharmaceuticals reported a net loss of $100.7M for Q2 2026, improving from a $112.0M loss in Q2 2025, driven by a 259% surge in product revenue to $44.7M. However, operating expenses rose 11% to $155.3M, and the accumulated deficit deepened to $761.5M from $561.7M at year-end 2025. Cash and marketable securities totaled $964.8M as of June 30, 2026, down from $1.16B at December 31, 2025.

• · Net loss per share improved to $(1.69) in Q2 2026 from $(1.93) in Q2 2025.
• · Cost of sales increased to $3.0M in Q2 2026 from $1.7M in Q2 2025.
• · Cash used in operating activities was $176.2M in H1 2026, compared to $188.6M in H1 2025.
• · Net cash provided by investing activities was $181.5M in H1 2026, down from $191.6M in H1 2025.
• · Stock-based compensation expense rose to $31.5M in H1 2026 from $26.1M in H1 2025.
• · Accounts receivable increased to $20.1M at June 30, 2026 from $10.6M at December 31, 2025.
• · Inventory decreased to $30.2M at June 30, 2026 from $32.9M at December 31, 2025.
• · Contract assets of $4.1M were recorded at June 30, 2026, compared to zero at year-end 2025.
• · Accumulated other comprehensive loss was $(1.8M) at June 30, 2026, versus income of $2.2M at December 31, 2025.
• · Total marketable securities (current and non-current) were $865.2M at June 30, 2026, down from $1.075B at December 31, 2025.

30-07-2026

AEP Transmission Company, LLC reported GAAP earnings of $192 million for the three months ended June 30, 2026, with no specified items adjustments, resulting in operating earnings (Non-GAAP) also of $192 million. The filing is part of a combined Form 10-Q with American Electric Power and its subsidiaries, covering legal proceedings, risk factors, and other standard quarterly disclosures. No period-over-period comparisons are provided in the excerpt, limiting trend analysis.

• · AEPTCo is a wholly-owned subsidiary of AEP Transmission Holdco, which is a subsidiary of AEP.
• · AEPTCo owns the State Transcos and Midwest Transmission Holdings.
• · The filing includes risk factors related to wildfires, extreme weather, cybersecurity, AI adoption, and data center demand uncertainty.
• · No period-over-period comparisons are available in the provided excerpt.

30-07-2026

30-07-2026

Omega Healthcare Investors reported strong Q2 2026 results with net income available to common stockholders of $362.8M ($1.21 basic EPS) vs $136.6M ($0.46) in Q2 2025, driven by a $246.5M gain on asset sales. Total revenues grew 16.2% to $328.2M. However, property-level expenses surged to $16.2M from $3.8M, and general & administrative expenses nearly doubled to $42.0M. For the six months, net income available to common stockholders was $513.9M ($1.68 basic EPS) vs $245.6M ($0.80) in the prior year period.

• · Basic EPS for Q2 2026 was $1.21 vs $0.46 in Q2 2025; diluted EPS was $1.19 vs $0.46.
• · For H1 2026, basic EPS was $1.68 vs $0.80; diluted EPS was $1.66 vs $0.79.
• · Total assets decreased slightly from $10.05B (Dec 2025) to $10.01B (Jun 2026).
• · Cash and cash equivalents increased from $27.0M to $39.0M; restricted cash increased from $27.5M to $145.2M.
• · Revolving credit facility balance decreased from $242M to $6M.
• · Senior notes and other unsecured borrowings remained relatively flat at $4.02B.
• · Net cash provided by operating activities for H1 2026 was $433.2M vs $421.2M in H1 2025.
• · Net cash provided by investing activities was $282.0M (vs used $444.3M in H1 2025) due to higher proceeds from asset sales.
• · Net cash used in financing activities was $584.8M (vs provided $241.3M in H1 2025) due to net debt repayments.
• · Dividends declared were $0.67 per share in both Q2 2026 and Q2 2025.
• · Impairment on real estate properties was $0 in Q2 2026 vs $14.2M in Q2 2025.
• · Recovery for credit losses was $5.0M in Q2 2026 vs $4.8M in Q2 2025.

30-07-2026

AGCO Corporation reported a sharp decline in net income for Q2 2026, with net income attributable to AGCO falling 75.5% to $77.2M from $314.8M in Q2 2025. Net sales slipped slightly by 1.0% to $2,609.7M. For the first half of 2026, net income attributable to AGCO dropped 59.4% to $132.2M from $325.3M, while net sales rose 5.7% to $4,952.6M. The company also generated negative operating cash flow of $245.0M in the first six months, compared to positive $153.5M a year earlier, and reduced its share count through $347.0M in buybacks.

• · Gross profit margin declined slightly: Q2 2026 gross profit was $645.9M (24.7% of sales) vs $658.6M (25.0% of sales) in Q2 2025.
• · Engineering expenses increased 19.9% YoY in Q2 2026 to $141.2M from $117.8M.
• · Selling, general and administrative expenses rose 2.9% YoY in Q2 2026 to $335.7M from $326.4M.
• · Income from operations fell 14.2% YoY in Q2 2026 to $140.7M from $164.0M.
• · The company recorded a $2.1M impairment charge in H1 2026 (vs $7.9M in H1 2025).
• · Inventories increased 11.0% to $3,007.1M at June 30, 2026 from $2,709.3M at December 31, 2025.
• · Borrowings due within one year surged to $546.7M from $117.7M at year-end 2025.
• · Total stockholders' equity decreased 4.5% to $4,080.6M from $4,273.5M at December 31, 2025.
• · The company repurchased approximately 2.6 million shares in H1 2026 (shares outstanding fell from 72.6M to 70.0M).

30-07-2026

Lincoln Electric Holdings reported strong Q2 2026 results with net sales of $1.22B (+12.0% YoY) and net income of $158.5M (+10.5% YoY). All three segments—Consumables, Equipment, and Automation—grew year-over-year. However, cash and cash equivalents declined 21.5% from $308.8M at year-end 2025 to $242.4M, driven by heavy share repurchases ($132.8M in H1) and dividend payments ($87.5M). The company also reported a negative currency translation adjustment of ($6.0M) for the six-month period, contributing to a decline in comprehensive income.

• · Rationalization and asset impairment charges were $3.5M in Q2 2026 vs $2.5M in Q2 2025.
• · Interest expense net was $12.5M in Q2 2026, roughly flat vs $12.6M in Q2 2025.
• · Other expense was ($0.2M) in Q2 2026 vs other income of $4.0M in Q2 2025, a $4.3M swing.
• · The effective tax rate was 23.7% in Q2 2026 vs 21.9% in Q2 2025.
• · Goodwill remained essentially flat at $885.2M vs $886.7M at year-end.
• · Total debt was $1.15B, unchanged from year-end; short-term debt was fully repaid ($143.8M at Dec 31, 2025 to $0).
• · Share repurchases accelerated: $76.1M in Q2 alone vs $56.7M in Q1 2026.
• · The company adopted no new accounting standards early; ASU 2024-03 (expense disaggregation) is effective 2027/2028 and early adoption is prohibited.

30-07-2026

Pitney Bowes reported net income of $49.9M for Q2 2026, up 66.5% from $30.0M in Q2 2025, driven by a 8.7% decline in total costs and expenses. However, total revenue declined 2.3% to $451.5M, with Presort Services revenue falling 5.1% to $142.6M, partially offset by a slight increase in SendTech Solutions revenue. The company's balance sheet shows a stockholders' deficit of $863.3M, worsening from $802.4M at year-end 2025, and cash flow from operations improved to $197.1M in H1 2026 from $94.7M in H1 2025.

• · Diluted net income per share was $0.36 in Q2 2026, up from $0.17 in Q2 2025.
• · Restructuring charges decreased to $3.3M in Q2 2026 from $13.8M in Q2 2025.
• · Selling, general and administrative expenses fell 24.5% to $128.7M in Q2 2026 from $170.5M in Q2 2025.
• · Interest expense, net increased 14.6% to $28.6M in Q2 2026 from $24.9M in Q2 2025.
• · Long-term debt increased to $2.01B at June 30, 2026 from $1.98B at December 31, 2025.
• · The company repurchased $188.4M of common stock in H1 2026, more than double the $90.3M in H1 2025.
• · Dividends paid to stockholders were $26.9M in H1 2026, up from $23.6M in H1 2025.
• · Accounts payable and accrued liabilities decreased 12.1% to $743.2M from $845.4M at year-end 2025.
• · Goodwill decreased slightly to $740.4M from $746.7M at year-end 2025.

30-07-2026

Service Corporation International (SCI) reported mixed results for Q2 2026. Total revenue increased 3.6% YoY to $1.103B in Q2 and 2.8% to $2.200B for the first half, driven by growth in property/merchandise, service, and other revenue. However, net income attributable to common stockholders for the six-month period declined 1.9% to $260.6M from $265.7M, and comprehensive income fell sharply due to unfavorable foreign currency translation. Operating cash flow improved significantly to $572.4M (H1 2026) from $477.6M (H1 2025), while the company continued aggressive share repurchases ($266.4M in H1 2026) and increased capital spending.

• · Total comprehensive income attributable to common stockholders fell 19.3% in H1 2026 to $244.5M from $286.9M in H1 2025, driven by a $16.1M foreign currency translation loss vs a $21.1M gain in the prior year.
• · Gross profit for H1 2026 was essentially flat at $560.0M vs $562.9M in H1 2025, a decline of 0.5%.
• · Operating income for H1 2026 was $475.4M, nearly unchanged from $476.1M in H1 2025.
• · Capital expenditures increased 8.9% to $175.6M in H1 2026 from $161.2M in H1 2025.
• · Business acquisitions totaled $39.5M in H1 2026, up from $28.2M in H1 2025.
• · The company spent $266.4M on share repurchases in H1 2026, down 17.8% from $324.0M in H1 2025.
• · Dividends paid increased 5.7% to $96.4M in H1 2026 from $91.1M in H1 2025.
• · Total debt (current maturities + long-term) increased to $5.303B at June 30, 2026 from $5.140B at December 31, 2025.
• · Total equity decreased 6.2% to $1.538B at June 30, 2026 from $1.639B at December 31, 2025, primarily due to share repurchases and dividends exceeding net income.
• · Preneed deposits grew 11.0% in Q2 2026 to $176.0M from $158.5M in Q2 2025.